Columbus Venture Partners

Rounds

• A Accipiter BiosciencesDesigns de novo multifunctional protein biologics for complex diseases $12.7MSeed · 6 Nov
• H Highlight TherapeuticsDevelops cancer immunotherapies, lead compound BO-112, in Phase 2b for skin cancer $17.7M16 Sept
• I Integra TherapeuticsFiCAT gene writing platform combining CRISPR accuracy with a transposase $12.5MVenture · 8 Sept

No round matches these filters.

Often invests with

• AdBio Partners1
• Alexandria Venture Investments1
• Buenavista Equity Partners1
• CDTI Innvierte1
• Cercano Capital1
• EIC Fund1
• Flying Fish Partners1
• Invivo Partners1